Exon-skipping brain natriuretic peptide variant is overexpressed in failing myocardium and attenuates brain natriuretic peptide production in vitro

Experimental Biology and Medicine

Volumn 235, Issue 8, 2010, Pages 941-951

  Torrado, Mario ^a   Iglesias, Raquel ^a   Centeno, Alberto ^b   López, Eduardo ^b   Mikhailov, Alexander T ^a  

^a UNIVERSITY OF A CORUÑA   (Spain)

^b University Hospital of La Coruña   (Spain)

Author keywords

Exon skipping; Heart failure; Myocardium; NPPB; Post transcriptional regulation

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; MESSENGER RNA;

ALTERNATIVE RNA SPLICING; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DIASTOLIC HEART FAILURE; DOWN REGULATION; EXON SKIPPING; GENE CONTROL; GENE EXPRESSION; HEART MUSCLE; HUMAN; NEGATIVE FEEDBACK; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; PIGLET; POSTNATAL DEVELOPMENT; ADULT; ANIMAL; BIOSYNTHESIS; DRUG EFFECTS; EXON; GENETICS; HEART FAILURE; METABOLISM; PATHOLOGY; PHYSIOLOGY; SWINE; UPREGULATION;

ADULT; ALTERNATIVE SPLICING; ANIMALS; BASE SEQUENCE; EXONS; HEART FAILURE; HUMANS; MYOCARDIUM; NATRIURETIC PEPTIDE, BRAIN; RNA, MESSENGER; SWINE; UP-REGULATION;

SUIDAE; SUS;

EID: 77955704774     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1258/ebm.2010.010078     Document Type: Article

References (30)

1. Vanderheyden M, Bartunek J, Goethals M. Brain and other natriuretic peptides: molecular aspects. Eur J Heart Fail 2004;6:261-8 (Pubitemid 38253044)
2. Nakayama T. The genetic contribution of the natriuretic peptide system to cardiovascular diseases. Endocr J 2005;52:11-21 (Pubitemid 40410313)
3. Burke MA, Cotts WG. Interpretation of B-type natriuretic peptide in cardiac disease and other comorbid conditions. Heart Fail Rev 2007;12:23-36 (Pubitemid 46629244)
4. Zakynthinos E, Kiropoulos T, Gourgoulianis K, Filippatos G. Diagnostic and prognostic impact of brain natriuretic peptide in cardiac and noncardiac diseases. Heart Lung 2008;37:275-85 (Pubitemid 351938694)
5. Iwanaga Y, Nishi I, Furuichi S, Noguchi T, Sase K, Kihara Y, Goto Y, Nonogi H. B-type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure: comparison between systolic and diastolic heart failure. J Am Coll Cardiol 2006;47:742-8 (Pubitemid 43243094)
6. Grewal J, McKelvie RS, Persson H, Tait P, Carlsson J, Swedberg K, Ostergren J, Lonn E. Usefulness of N-terminal pro-brain natriuretic peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction. Am J Cardiol 2008;102:733-7
7. Grewal J, McKelvie R, Lonn E, Tait P, Carlsson J, Gianni M, Jarnert C, Persson H. BNP and NT-proBNP predict echocardiographic severity of diastolic dysfunction. Eur J Heart Fail 2008;10:252-9 (Pubitemid 351343862)
8. LaPointe MC. Molecular regulation of the brain natriuretic peptide gene. Peptides 2005;26:944-56
9. Mair J. Biochemistry of B-type natriuretic peptide - where are we now? Clin Chem Lab Med 2008;46:1507-14
10. Vanderheyden M, Goethals M, Verstreken S, De Bruyne B, Muller K, Van Schuerbeeck E, Bartunek J. Wall stress modulates brain natriuretic peptide production in pressure overload cardiomyopathy. J Am Coll Cardiol 2004;44:2349-54 (Pubitemid 39647609)
11. Frank D, Kuhn C, Brors B, Hanselmann C, Ludde M, Katus HA, Frey N. Gene expression pattern in biomechanically stretched cardiomyocytes: evidence for a stretch-specific gene program. Hypertension 2008;51:309-18 (Pubitemid 351159944)
12. Majalahti T, Suo-Palosaari M, Sarman B, Hautala N, Pikkarainen S, Tokola H, Vuolteenaho O, Wang J, Paradis P, Nemer M, Ruskoaho H. Cardiac BNP gene activation by angiotensin II in vivo. Mol Cell Endocrinol 2007;273:59-67 (Pubitemid 47016746)
13. Suo M, Hautala N, Foldes G, Szokodi I, Toth M, Leskinen H, Uusimaa P, Vuolteenaho O, Nemer M, Ruskoaho H. Posttranscriptional control of BNP gene expression in angiotensin II-induced hypertension. Hypertension 2002;39:803-8 (Pubitemid 34252880)
14. Tenhunen O, Szokodi I, Ruskoaho H. Posttranscriptional activation of BNP gene expression in response to increased left ventricular wall stress: role of calcineurin and PKC. Regul Pept 2005;128:187-96 (Pubitemid 40544833)
15. Pan S, Chen HH, Dickey DM, Boerrigter G, Lee C, Kleppe LS, Hall JL, Lerman A, Redfield MM, Potter LR, Burnett JC Jr, Simari RD. Biodesign of a renal-protective peptide based on alternative splicing of B-type natriuretic peptide. Proc Natl Acad Sci USA 2009;106:11282-7
16. Torrado M, Iglesias R, Nespereira B, Mikhailov AT. Identification of candidate genes potentially relevant to chamber-specific remodeling in postnatal ventricular myocardium. J Biomed Biotechnol 2010; doi: 10.1155/2010/603159
17. Torrado M, Lopez E, Centeno A, Castro-Beiras A, Mikhailov AT. Left-right asymmetric ventricular expression of CARP in the piglet heart: regional response to experimental heart failure. Eur J Heart Fail 2004;6:161-72 (Pubitemid 38249359)
18. Torrado M, Centeno C, López E, Mikhailov AT. In-vivo forced expression of myocardin in ventricular myocardium transiently impairs systolic performance in early neonatal pig heart. Int J Dev Biol 2009;53:1457-67
19. Torrado M, Nespereira B, Bouzamayor Y, Centeno A, Lopez E, Mikhailov AT. Differential atrial versus ventricular ANKRD1 gene expression is oppositely regulated at diastolic heart failure. FEBS Lett 2006;580:4182-7 (Pubitemid 44037590)
20. Torrado M, Lopez E, Centeno A, Medrano C, Castro-Beiras A, Mikhailov AT. Myocardin mRNA is augmented in the failing myocardium: expression profiling in the porcine model and human dilated cardiomyopathy. J Mol Med 2003;81:566-77 (Pubitemid 37214995)
21. Torrado M, Iglesias R, Nespereira B, Centeno A, Lopez E, Mikhailov AT. Intron retention generates ANKRD1 splice variants that are co-regulated with the main transcript in normal and failing myocardium. Gene 2009;440:28-41
22. David A, Tiveron MC, Defays A, Beclin C, Camosseto V, Gatti E, Cremer H, Pierre P. BAD-LAMP defines a subset of early endocytic organelles in subpopulations of cortical projection neurons. J Cell Sci 2007;120:353-65 (Pubitemid 46243252)
23. 2+ signalling and gene expression. J Physiol 2004;554:309-20
24. Ronkainen JJ, Vuolteenaho O, Tavi P. Calcium-calmodulin kinase II is the common factor in calcium-dependent cardiac expression and secretion of A- and B-type natriuretic peptides. Endocrinology 2007;148:2815-20 (Pubitemid 46984803)
25. Nader L, Smayra V, Jebara V, Bois P, Potreau D, Fares N. Brain natriuretic peptide secretion in adult rat heart muscle cells: the role of calcium channels. Arch Cardiovasc Dis 2008;101:459-63
26. McGlincy NJ, Smith CW. Alternative splicing resulting in nonsense-mediated mRNA decay: what is the meaning of nonsense? Trends Biochem Sci 2008;33:385-93
27. Bashyam MD. Nonsense-mediated decay: linking a basic cellular process to human disease. Expert Rev Mol Diagn 2009;9:299-303
28. Chen HH. Heart failure: a state of brain natriuretic peptide deficiency or resistance or both! J Am Coll Cardiol 2007;49:1089-91
29. Marchler-Bauer A, Anderson JB, Chitsaz F, Derbyshire MK, DeWeese-Scott C, Fong JH, Geer LY, Geer RC, Gonzales NR, Gwadz M, He S, Hurwitz DI, Jackson JD, Ke Z, Lanczycki CJ, Liebert CA, Liu C, Lu F, Lu S, Marchler GH, Mullokandov M, Song JS, Tasneem A, Thanki N, Yamashita RA, Zhang D, Zhang N, Bryant SH. CDD: specific functional annotation with the Conserved Domain Database. Nucleic Acids Res 2009;37:D205-10
30. Arai M, Mitsuke H, Ikeda M, Xia JX, Kikuchi T, Satake M, Shimizu T. ConPred II: a consensus prediction method for obtaining transmembrane topology models with high reliability. Nucleic Acids Res 2004;32:W390-3